{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:17:38Z","timestamp":1787249858674,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd003225","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"record-id":"31032"},{"DOI":"10.1002\/14651858.cd003225.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"record-id":"31031"},{"DOI":"10.1002\/14651858.cd003225.pub2","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000}}],"reference-count":111,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003225.pub3","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T18:50:10Z","timestamp":1487357410000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Propranolol for migraine prophylaxis"],"prefix":"10.1002","author":[{"given":"Klaus","family":"Linde","sequence":"first","affiliation":[{"name":"Technical University Munich; Centre for Complementary Medicine Research, Department of Internal Medicine II; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Rossnagel","sequence":"additional","affiliation":[{"name":"Charit\u00e9 University Hospital; Institute of Social Medicine & Epidemiology; Humboldt University Berlin Germany 10098"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"10.1002\/14651858.CD003225.pub3-BIB1|cit1","first-page":"263","article-title":"Propranolol in prophylaxis of migraine","volume":"82","author":"Ahuja","year":"1985","journal-title":"Indian Journal of Medical Research"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1526-4610.1989.hed22904215.x","article-title":"Nifedipine versus propranolol for the initial prophylaxis of migraine","volume":"29","author":"Albers","year":"1989","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1468-2982.1993.1302128.x","article-title":"Comparison of propranolol LA 80 mg and propranolol LA 160 mg in mirgraine prophylaxis: a placebo controlled study","volume":"13","author":"Al-Qassab","year":"1993","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1981.tb04407.x","article-title":"Propranolol and femoxetine, a 5HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study","volume":"64","author":"Andersson","year":"1981","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0404.1983.tb04561.x","article-title":"Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study","volume":"67","author":"Baldrati","year":"1983","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1340","key":"10.1002\/14651858.CD003225.pub3-BIB6|cit6","first-page":"201","article-title":"Propranolol in the treatment of migraine","volume":"224","author":"Behan","year":"1980","journal-title":"Practitioner"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1212\/WNL.51.5.1475","article-title":"Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test","volume":"51","author":"Bonuso","year":"1998","journal-title":"Neurology"},{"issue":"3B","key":"10.1002\/14651858.CD003225.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1590\/S0004-282X1997000400003","article-title":"Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial","volume":"55","author":"Bordini","year":"1997","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"0","key":"10.1002\/14651858.CD003225.pub3-BIB11|cit9","first-page":"163","article-title":"Treatment of migraine with propranolol","volume":"52 Suppl 4","author":"Borgesen","year":"1976","journal-title":"Postgraduate Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB9|cit10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0404.1974.tb02810.x","article-title":"Prophylactic treatment of migraine with propranolol. A clinical trial","volume":"50","author":"Borgesen","year":"1974","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7871","key":"10.1002\/14651858.CD003225.pub3-BIB10|cit11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(74)91405-6","article-title":"Propranolol in migraine","volume":"2","author":"Borgesen","year":"1974","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003225.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/03331024870070S6204","article-title":"No clearcut longterm prophylactic effect of one month of treatment with propranolol in migraineurs","volume":"7 Suppl 6","author":"Dahl\u00f6f","year":"1987","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1526-4610.1976.hed1601024.x","article-title":"Double blind study of propranolol for migraine prophylaxis","volume":"16","author":"Diamond","year":"1976","journal-title":"Headache"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1526-4610.1982.hed2206268.x","article-title":"Long-term study of propanolol in the treatment of migraine","volume":"22","author":"Diamond","year":"1982","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.410250204","article-title":"Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials","volume":"25","author":"Diener","year":"1989","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1468-2982.1991.1101037.x","article-title":"Responders and non-responders to metoprolol, propanolol and nifidepine treatment in migraine prophylaxis: a dose-range study based on time-series analysis","volume":"11","author":"Gerber","year":"1991","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1468-2982.1996.1606441.x","article-title":"Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propanolol","volume":"16","author":"Diener","year":"1996","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB19|cit18","first-page":"374","article-title":"Efficacy and tolerability of flunarizine and propranolol in the prophylactic treatment of migraine","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB18|cit19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1468-2982.2002.t01-1-00309.x","article-title":"Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily [published erratum appears in Cephalalgia 2002;22(6):488]","volume":"22","author":"Diener","year":"2002","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00280110","article-title":"Nimodipine in migraine: clinical efficacy and endocrinological effects","volume":"41","author":"Formisano","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1526-4610.1976.hed1605238.x","article-title":"Propranolol for migraine prophylaxis","volume":"16","author":"Forssman","year":"1976","journal-title":"Headache"},{"key":"10.1002\/14651858.CD003225.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0333102491011S1184","article-title":"Flunarizine is comparable to propranolol in the prophylaxis of migraine with and without aura","volume":"11 Suppl 11","author":"Gawel","year":"1991","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1017\/S0317167100041962","article-title":"Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine","volume":"19","author":"Gawel","year":"1992","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB24|cit24","first-page":"27","article-title":"Cyclandelate versus propranolol in the prophylaxis of migraine - a double-blind placebo-controlled study","volume":"10","author":"Gerber","year":"1995","journal-title":"Functional Neurology"},{"key":"10.1002\/14651858.CD003225.pub3-BIB25|cit25","first-page":"183","article-title":"On the long-term effect of cyclandelate and propranolol in migraine after stopping a four-month drug prophylaxis","volume":"16","author":"Schellenberg","year":"1997","journal-title":"Nervenheilkunde"},{"issue":"45","key":"10.1002\/14651858.CD003225.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1055\/s-2008-1068322","article-title":"Betablocker vs placebo in vasomotor headache. A double-blind crossover study","volume":"112","author":"Grotemeyer","year":"1987","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1600-0404.1986.tb07873.x","article-title":"The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients","volume":"74","author":"Hedman","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"issue":"25","key":"10.1002\/14651858.CD003225.pub3-BIB28|cit28","first-page":"1115","article-title":"Propranolol for migraine prophylaxis: a double-blind study","volume":"72","author":"Holdorff","year":"1977","journal-title":"Medizinische Klinik"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0404.1986.tb04591.x","article-title":"Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis","volume":"73","author":"Johnson","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0404.1983.tb04836.x","article-title":"Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine","volume":"68","author":"Kangasniemi","year":"1983","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1468-2982.1984.0402091.x","article-title":"Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study","volume":"4","author":"Kangasniemi","year":"1984","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0404.1984.tb07773.x","article-title":"Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetine","volume":"69","author":"Nyrke","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"issue":"9","key":"10.1002\/14651858.CD003225.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archneur.1997.00550210071015","article-title":"A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura","volume":"54","author":"Kaniecki","year":"1997","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1600-0404.1980.tb01504.x","article-title":"Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial","volume":"61","author":"Kass","year":"1980","journal-title":"Acta Neurologica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1600-0404.1994.tb02664.x","article-title":"Tolfenamic acid versus propranolol in the prophylactic treatment of migraine","volume":"89","author":"Kjaersgard Rasmussen","year":"1994","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB36|cit36","first-page":"50","article-title":"An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches","volume":"5","author":"Klapper","year":"1994","journal-title":"Headache Quarterly"},{"key":"10.1002\/14651858.CD003225.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/03331024870070S6203","article-title":"Prophylactic treatment of migraine with long acting propranolol - a comparison with placebo","volume":"7 Suppl 6","author":"Kuritzky","year":"1987","journal-title":"Cephalalgia"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD003225.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/03331024880080S805","article-title":"Flunarizine versus propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients","volume":"8","author":"L\u00fccking","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD003225.pub3-BIB39|cit39","first-page":"177","article-title":"Flunarizine versus propranolol in migraine prophylaxis - A multicenter double-blind study in 12 hospitals","volume":"6","author":"Soyka","year":"1987","journal-title":"Nervenheilkunde"},{"key":"10.1002\/14651858.CD003225.pub3-BIB40|cit40","first-page":"22","article-title":"Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients","volume":"8 Suppl 8","author":"L\u00fccking","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD003225.pub3-BIB41|cit41","first-page":"45","article-title":"Flunarizine versus propranolol in the interval treatment of migraine","volume":"9","author":"Soyka","year":"1990","journal-title":"Nervenheilkunde"},{"key":"10.1002\/14651858.CD003225.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/03331024870070S6209","article-title":"Therapeutic effectiveness of flunarizine and propranolol in the interval therapy of migraine","volume":"7 Suppl 6","author":"Soyka","year":"1987","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1526-4610.1989.hed22904219.x","article-title":"Flunarizine and propranolol in the treatment of migraine","volume":"29","author":"Ludin","year":"1989","journal-title":"Headache"},{"issue":"43","key":"10.1002\/14651858.CD003225.pub3-BIB44|cit44","first-page":"1585","article-title":"Comparative efficacy of 5-hydroxytryptophan and propranolol in interval treatment of migraine","volume":"121","author":"Maissen","year":"1991","journal-title":"Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1526-4610.1973.hed1204163.x","article-title":"Propranolol prophylaxis of migraine","volume":"12","author":"Malvea","year":"1973","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"105-9. [Study 1","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","article-title":"Prophylaxis of migraine and mixed headache. A randomized controlled study","volume":"21","author":"Mathew","year":"1981","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"105-9 [Study 2","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","article-title":"Prophylaxis of migraine and mixed headache. A randomized controlled study","volume":"21","author":"Mathew","year":"1981","journal-title":"Headache"},{"key":"10.1002\/14651858.CD003225.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5414\/CPP39144","article-title":"Alpha-dihydroergocryptine and predictive factors in migraine prophylaxis","volume":"39","author":"Micieli","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB49|cit49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0404.1986.tb03299.x","article-title":"Prophylactic treatment of migraine with tolfenamic acid, propanolol and placebo","volume":"73","author":"Mikkelsen","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB50|cit50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1526-4610.1986.hed2604175.x","article-title":"Propranolol in the prophylaxis of migraine","volume":"26","author":"Nadelmann","year":"1986","journal-title":"Headache"},{"issue":"2-3","key":"10.1002\/14651858.CD003225.pub3-BIB51|cit51","first-page":"79","article-title":"The way to serotonergic use and abuse in migraine","volume":"17","author":"Nicolodi","year":"1997","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"10","key":"10.1002\/14651858.CD003225.pub3-BIB52|cit52","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1526-4610.1986.hed2610490.x","article-title":"Nadolol and propranolol in migraine management","volume":"26","author":"Olerud","year":"1986","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1984.tb00815.x","article-title":"Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study","volume":"70","author":"Olsson","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB54|cit54","first-page":"28","article-title":"Prophylactic propranolol in the treatment of headache","volume":"37","author":"Palferman","year":"1983","journal-title":"British Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB55|cit55","first-page":"273","article-title":"Propranolol and migraine. A clinical trial","volume":"3","author":"Pita","year":"1977","journal-title":"Archivos de Farmacologia y Toxicologia"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB56|cit56","first-page":"441","article-title":"Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo","volume":"45","author":"Pradalier","year":"1990","journal-title":"Th\u00e9rapie"},{"key":"10.1002\/14651858.CD003225.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/0333102489009S10196","article-title":"Double-blind placebo controlled study of the use of long-acting propranolol in migraine prophylaxis","volume":"9 Suppl 10","author":"Pradalier","year":"1989","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-2982.1989.904247.x","article-title":"Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study","volume":"9","author":"Pradalier","year":"1989","journal-title":"Cephalalgia"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD003225.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/0002-8703(84)90600-8","article-title":"Comparative study of nadolol and propranolol in prophylactic treatment of migraine","volume":"108","author":"Ryan","year":"1984","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1526-4610.1985.hed2506320.x","article-title":"A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache","volume":"25","author":"Sargent","year":"1985","journal-title":"Headache"},{"key":"10.1002\/14651858.CD003225.pub3-BIB61|cit61","first-page":"139","article-title":"Dihydroergotamine vs flunarizine vs nifidepine vs metoprolol vs propranolol in migraine prophylaxis: a comparative study based on time series analysis","volume-title":"Advances in headache research: proceedings of the 6th International Migraine Symposium","author":"Scholz","year":"1987"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB62|cit62","first-page":"75","article-title":"A comparative trial of flunarizine and propranolol in the prevention of migraine","volume":"77","author":"Shimell","year":"1990","journal-title":"South African Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB63|cit63","first-page":"325","article-title":"Verapamil and propranolol in migraine prophylaxis: a double-blind, crossover study","volume":"26","author":"Solomon","year":"1986","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB64|cit64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.1976.tb04342.x","article-title":"Short-term clinical trial of propranolol in racemic form (Inderal), D-propranolol and placebo in migraine","volume":"53","author":"Stensrud","year":"1976","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1526-4610.1980.h2004006.x","article-title":"Comparative trial of Tenormin (atenol) and Inderal (propranolol) in migraine","volume":"20","author":"Stensrud","year":"1980","journal-title":"Headache"},{"key":"10.1002\/14651858.CD003225.pub3-BIB66|cit66","first-page":"37","article-title":"Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine","volume":"31","author":"Stensrud","year":"1980","journal-title":"Upsala Journal of Medical Sciences - Supplement"},{"issue":"8","key":"10.1002\/14651858.CD003225.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1526-4610.1987.hed2708421.x","article-title":"Comparative efficacy of nadolol and propranolol in the management of migraine","volume":"27","author":"Sudilovsky","year":"1987","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1468-2982.1982.0203165.x","article-title":"The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine","volume":"2","author":"Standnes","year":"1982","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","article-title":"Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial","volume":"69","author":"Tfelt-Hansen","year":"1984","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB70|cit70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.22.4.366","article-title":"The treatment of migraine with propranolol","volume":"22","author":"Weber","year":"1972","journal-title":"Neurology"},{"issue":"921","key":"10.1002\/14651858.CD003225.pub3-BIB71|cit71","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.2.5921.699","article-title":"Propranolol in the treatment of migraine","volume":"2","author":"Wideroe","year":"1974","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB72|cit72","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1987.00520170016015","article-title":"Migraine prophylaxis. A comparison of propranolol and amitriptyline","volume":"44","author":"Ziegler","year":"1987","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003225.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/archneur.1993.00540080036010","article-title":"Propranolol and amitriptyline in the prophylaxis of migraine. Pharmacokinetic and therapeutic effects","volume":"50","author":"Ziegler","year":"1993","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD003225.pub3-BIB74|cit74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/03331024880080S803","article-title":"Onset of action of various migraine prophylactics","volume":"8 Suppl 8","author":"Amery","year":"1988","journal-title":"Cephalalgia"},{"issue":"19","key":"10.1002\/14651858.CD003225.pub3-BIB75|cit75","first-page":"77","article-title":"Propranolol for prevention of migraine headaches","volume":"21","author":"Anonymous","year":"1979","journal-title":"Medical Letter on Drugs & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB76|cit76","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1468-2982.1991.1104193.x","article-title":"Propranolol in the treatment of acute migraine attacks","volume":"11","author":"Banerjee","year":"1991","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB77|cit77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-2982.1990.1002101.x","article-title":"Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses","volume":"10","author":"Carroll","year":"1990","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB78|cit78","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.1985.04060010052015","article-title":"Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects","volume":"42","author":"Cortelli","year":"1985","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB79|cit79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1008617825269","article-title":"A postmarketing study of flunarizine in migraine and vertigo","volume":"19","author":"Bock","year":"1997","journal-title":"Pharmacy World & Science"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1526-4610.1987.hed2702070.x","article-title":"Long-acting propranolol in the prophylaxis of migraine","volume":"27","author":"Diamond","year":"1987","journal-title":"Headache"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1468-2982.1990.1005229.x","article-title":"Propranolol in acute migraine: a controlled study","volume":"10","author":"Fuller","year":"1990","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1002\/14651858.CD003225.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1526-4610.1988.hed2809607.x","article-title":"Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg","volume":"28","author":"Havanka-Kanniainen","year":"1988","journal-title":"Headache"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB83|cit83","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1037\/0022-006X.63.2.327","article-title":"Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride","volume":"63","author":"Holroyd","year":"1995","journal-title":"Journal of Consulting & Clinical Psychology"},{"issue":"10","key":"10.1002\/14651858.CD003225.pub3-BIB84|cit84","first-page":"653","article-title":"Preventive treatment of migraine with propranolol (letter)","volume":"5","author":"Julien","year":"1976","journal-title":"Nouvelle Presse M\u00e9dicale"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB85|cit85","first-page":"381","article-title":"Calcium channel blockers and prevention of migraine","volume":"40","author":"Montastruc","year":"1992","journal-title":"Pathologie et Biologie"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB86|cit86","first-page":"300","article-title":"Drug vs. behavioral treatment of migraine: long-acting propranolol vs. home-based self-management training","volume":"30","author":"Penzien","year":"1990","journal-title":"Headache"},{"issue":"35","key":"10.1002\/14651858.CD003225.pub3-BIB87|cit87","first-page":"1805","article-title":"Metoprolol, a new effective antimigraine agent","volume":"17","author":"Raveau-Landon","year":"1988","journal-title":"Presse Medicale"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB88|cit88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.410130119","article-title":"Observations on the efficacy of propranolol for the prophylaxis of migraine","volume":"13","author":"Rosen","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003225.pub3-BIB89|cit89","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00005344-199118081-00008","article-title":"Flunarizine in migraine prophylaxis: the clinical experience","volume":"18 Suppl 8","author":"Schmidt","year":"1991","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB90|cit90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1526-4610.1981.hed2103089.x","article-title":"Mechanism of the biofeedback therapy of migraine: volitional manipulation of the psychophysiological background","volume":"21","author":"Sovak","year":"1981","journal-title":"Headache"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB91|cit91","first-page":"196","article-title":"Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide","volume":"4","author":"Steardo","year":"1982","journal-title":"Acta Neurologica"},{"key":"10.1002\/14651858.CD003225.pub3-BIB92|cit92","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/03331024860060S502","article-title":"Efficancy of beta-blockers in migraine. A critical review","volume":"6 Suppl 5","author":"Tfelt-Hansen","year":"1986","journal-title":"Cephalalgia"},{"key":"10.1002\/14651858.CD003225.pub3-BIB93|cit93","first-page":"51","article-title":"Beta-blocking drugs in migraine","volume":"60 Suppl 2","author":"Turner","year":"1984","journal-title":"Postgraduate Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1468-2982.1996.1605328.x","article-title":"Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine","volume":"16","author":"Verspeelt","year":"1996","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002280050154","article-title":"Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine","volume":"51","author":"Verspeelt","year":"1996","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB96|cit96","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2362.1990.tb01866.x","article-title":"Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade","volume":"20","author":"Winther","year":"1990","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"10.1002\/14651858.CD003225.pub3-BIB97|cit97","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1468-2982.1991.1106251.x","article-title":"Long-term results of migraine prophylaxis with flunarizine and beta-blockers","volume":"11","author":"Wober","year":"1991","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1002\/14651858.CD003225.pub3-BIB98|cit98","first-page":"501","article-title":"The use of propranolol on migraine prophylaxis: a double-blind clinical trials comparing propranolol with an analgesic drug (acetaminophen) and placebo","volume":"77","author":"Bernik","year":"1978","journal-title":"Folha m\u00e9dica (Rio de Janeiro)"},{"issue":"3","key":"10.1002\/14651858.CD003225.pub3-BIB99|cit99","first-page":"223","article-title":"A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis","volume":"48","author":"Rao","year":"2000","journal-title":"Neurology India"},{"issue":"9","key":"10.1002\/14651858.CD003225.pub3-BIB100|cit100","first-page":"717","article-title":"Classification of headache","volume":"179","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003225.pub3-BIB101|cit101","unstructured":"Clarke M Oxman AD Optimal search strategy for RCTs. Cochrane Reviewers' Handbook 4.1.6 [updated January 2003]; Appendix 5c. In: The Cochrane Library, Issue 1, 2003 Oxford Update Software"},{"key":"10.1002\/14651858.CD003225.pub3-BIB102|cit102","unstructured":"Gray RN Goslin RE McCrory DC Eberlein K Tulsky J Hasselblad V Drug treatments for the prevention of migraine headache Technical review 2.3. February 1999. Prepared for the Agency for Health Care Policy and Research under Contract No. 290-94-2025. Available at: http:\/\/www.clinpol.mc.duke.edu (accessed 20 February 2004)"},{"issue":"5","key":"10.1002\/14651858.CD003225.pub3-BIB103|cit103","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1526-4610.1991.hed3105333.x","article-title":"Propranolol in the management of recurrent migraine: a meta-analytic review","volume":"31","author":"Holroyd","year":"1991","journal-title":"Headache"},{"key":"10.1002\/14651858.CD003225.pub3-BIB104|cit104","first-page":"1","article-title":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","volume":"8 Suppl 7","year":"1988","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1002\/14651858.CD003225.pub3-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD003225.pub3-BIB106|cit106","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"issue":"9","key":"10.1002\/14651858.CD003225.pub3-BIB107|cit107","first-page":"1273","article-title":"Guidelines for the diagnosis and management of migraine in clinical practice [published erratum appears in CMAJ 1997;157(10):1354]","volume":"156","author":"Pryse-Phillips","year":"1997","journal-title":"CMAJ"},{"issue":"2","key":"10.1002\/14651858.CD003225.pub3-BIB108|cit108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1468-2982.1997.1702073.x","article-title":"Migraine prophylactic drugs: proof of efficacy, utilization and cost","volume":"17","author":"Ramadan","year":"1997","journal-title":"Cephalalgia"},{"issue":"6 Suppl 4","key":"10.1002\/14651858.CD003225.pub3-BIB109|cit109","first-page":"S17","article-title":"Migraine prevalence. A review of population-based studies","volume":"44","author":"Stewart","year":"1994","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003225.pub3-BIB110|cit110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1468-2982.2000.00117.x","article-title":"Guidelines for controlled trials of drugs for migraine: second edition","volume":"20","author":"Tfelt-Hansen","year":"2000","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1002\/14651858.CD003225.pub3-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003225.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:17:41Z","timestamp":1628543861000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003225.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":111,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003225.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]}}}